Influenza A virus inhibits alveolar fluid clearance in BALB/c mice

American Journal of Respiratory and Critical Care Medicine

Volumn 178, Issue 9, 2008, Pages 969-976

  Wolk, Kendra E ^a   Lazarowski, Eduardo R ^b   Traylor, Zachary P ^a   Yu, Erin N Z ^a   Jewell, Nancy A ^a,c   Durbin, Russell K ^c   Durbin, Joan E ^a,c   Davis, Ian C ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

Adenosine; Ion transport; Orthomyxovirus infections; Pneumonia, viral; Pulmonary edema

Indexed keywords

ADENOSINE A1 RECEPTOR; ADENYLATE CYCLASE; AMILORIDE; PURINERGIC P2Y RECEPTOR; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL MODEL; ARTERIAL OXYGEN SATURATION; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ENZYME ACTIVATION; FEMALE; HYPOXEMIA; INFLUENZA; INFLUENZA VIRUS A; ION TRANSPORT; LUNG FLUID; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIRUS REPLICATION; WATER CONTENT;

ANIMALS; BIOLOGICAL TRANSPORT, ACTIVE; BODY WEIGHT; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; INFLUENZA A VIRUS; LUNG; MALE; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; OXYGEN; PERMEABILITY; TIME FACTORS;

EID: 55549100964     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200803-455OC     Document Type: Article

References (48)

1. Lynch JP III, Walsh EE. Influenza: evolving strategies in treatment and prevention. Semin Respir Crit Care Med 2007;28:144-158.
2. Taubenberger JK, Morens DM, Fauci AS. The next influenza pandemic: can it be predicted? JAMA 2007;297:2025-2027.
3. Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 2007;7:658-666.
4. Davis IC, Matalon S. Epithelial sodium channels in the adult lung: important modulators of pulmonary health and disease. Adv Exp Med Biol 2007;618:127-140.
5. Ware LB, Golden JA, Finkbeiner WE, Matthay MA. Alveolar epithelial fluid transport capacity in reperfusion lung injury after lung transplantation. Am J Respir Crit Care Med 1999;159:980-988.
6. + channels in respiratory epithelia. Proc Natl Acad Sci USA 2000;97:10282-10287.
7. Chen XJ, Seth S, Yue G, Kamat P, Compans RW, Guidot D, Brown LA, Eaton DC, Jain L. Influenza virus inhibits ENaC and lung fluid clearance. Am J Physiol Lung Cell Mol Physiol 2004;287:L366-L373.
8. Davis IC, Wolk KE, Yu ENZ. Influenza A virus inhibits alveolar fluid clearance in BALB/c mice. Am J Respir Crit Care Med 2008;177:A802.
9. Garcia-Sastre A, Durbin RK, Zheng H, Palese P, Gertner R, Levy DE, Durbin JE. The role of interferon in influenza virus tissue tropism. J Virol 1998;72:8550-8558.
10. Jewell NA, Vaghefi N, Mertz SE, Akter P, Peebles RS Jr, Bakaletz LO, Durbin RK, Flano E, Durbin JE. Differential type I interferon induction by respiratory syncytial virus and influenza A virus in vivo. J Virol 2007;81:9790-9800.
11. Davis IC, Sullender WM, Hickman-Davis JM, Lindsey JR, Matalon S. Nucleotide-mediated inhibition of alveolar fluid clearance in BALB/c mice after respiratory syncytial virus infection. Am J Physiol Lung Cell Mol Physiol 2004;286:L112-L120.
12. Saldias FJ, Lecuona E, Comellas AP, Ridge KM, Sznajder JI. Dopamine restores lung ability to clear edema in rats exposed to hyperoxia. Am J Respir Crit Care Med 1999;159:626-633.
13. Liu T, Ye Z. Attenuating mutations of the matrix gene of influenza A/WSN/33 virus. J Virol 2005;79:1918-1923.
14. Rocha MJ, Chen Y, Oliveira GR, Morris M. Physiological regulation of brain angiotensin receptor mRNA in AT1a deficient mice. Exp Neurol 2005;195:229-235.
15. Sidwell RW, Huffman JH, Gilbert J, Moscon B, Pedersen G, Burger R, Warren RP. Utilization of pulse oximetry for the study of the inhibitory effects of antiviral agents on influenza virus in mice. Antimicrob Agents Chemother 1992;36:473-476.
16. LeVine AM, Hartshorn K, Elliott J, Whitsett J, Korfhagen T. Absence of SP-A modulates innate and adaptive defense responses to pulmonary influenza infection. Am J Physiol Lung Cell Mol Physiol 2002;282:L563-L572.
17. Hennet T, Ziltener HJ, Frei K, Peterhans E. A kinetic study of immune mediators in the lungs of mice infected with influenza A virus. J Immunol 1992;149:932-939.
18. Quan FS, Huang C, Compans RW, Kang SM. Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus. J Virol 2007;81:3514-3524.
19. Davis IC, Xu A, Gao Z, Hickman-Davis JM, Factor P, Sullender WM, Matalon S. Respiratory syncytial virus induces insensitivity to β-adrenergic agonists in mouse lung epithelium in vivo. Am J Physiol Lung Cell Mol Physiol 2007;293:L281-L289.
20. Davis IC, Lazarowski ER, Hickman-Davis JM, Fortenberry JA, Chen FP, Zhao X, Sorscher E, Graves LM, Sullender WM, Matalon S. Leflunomide prevents alveolar fluid clearance inhibition by respiratory syncytial virus. Am J Respir Crit Care Med 2006;173:673-682.
21. Elder RT, Xu X, Williams JW, Gong H, Finnegan A, Chong AS. The immunosuppressive metabolite of leflunomide, A77 1726, affects murine T cells through two biochemical mechanisms. J Immunol 1997;159:22-27.
22. Okada SF, O'Neal WK, Huang P, Nicholas RA, Ostrowski LE, Craigen WJ, Lazarowski ER, Boucher RC. Voltage-dependent anion channel-1 (VDAC-1) contributes to ATP release and cell volume regulation in murine cells. J Gen Physiol 2004;124:513-526.
23. Maertens C, Wei L, Voets T, Droogmans G, Nilius B. Block by fluoxetine of volume-regulated anion channels. Br J Pharmacol 1999;126:508-514.
24. Nilius B, Voets T, Prenen J, Barth H, Aktories K, Kaibuchi K, Droogmans G, Eggermont J. Role of Rho and Rho kinase in the activation of volume-regulated anion channels in bovine endothelial cells. J Physiol 1999;516:67-74.
25. Cressman VL, Lazarowski E, Homolya L, Boucher RC, Koller BH, Grubb BR. Effect of loss of P2Y(2) receptor gene expression on nucleotide regulation of murine epithelial Cl(2) transport. J Biol Chem 1999;274:26461-26468.
26. Brunschweiger A, Muller CE. P2 receptors activated by uracil nucleotides - an update. Curr Med Chem 2006;13:289-312.
27. Lazarowski ER, Paradiso AM, Watt WC, Harden TK, Boucher RC. UDP activates a mucosal-restricted receptor on human nasal epithelial cells that is distinct from the P2Y2 receptor. Proc Natl Acad Sci USA 1997;94:2599-2603.
28. Fang X, Fukuda N, Barbry P, Sartori C, Verkman AS, Matthay MA. Novel role for CFTR in fluid absorption from the distal airspaces of the lung. J Gen Physiol 2002;119:199-207.
29. Hebestreit A, Kersting U, Hebestreit H. Hypertonic saline inhibits luminal sodium channels in respiratory epithelium. Eur J Appl Physiol 2007;100:177-183.
30. Lazarowski ER, Boucher RC, Harden TK. Constitutive release of ATP and evidence for major contribution of ecto-nucleotide pyrophosphatase and nucleoside diphosphokinase to extracellular nucleotide concentrations. J Biol Chem 2000;275:31061-31068.
31. Mutlu GM, Factor P. Alveolar epithelial b2-adrenergic receptors. Am J Respir Cell Mol Biol 2008;38:127-134.
32. Sartori C, Allemann Y, Duplain H, Lepori M, Egli M, Lipp E, Hutter D, Turini P, Hugli O, Cook S, et al. Salmeterol for the prevention of high-altitude pulmonary edema. N Engl J Med 2002;346:1631-1636.
33. Perkins GD, McAuley DF, Thickett DR, Gao F. The β-agonist lung injury trial (BALTI): a randomized placebo-controlled clinical trial. Am J Respir Crit Care Med 2006;173:281-287.
34. Licker M, Tschopp JM, Robert J, Frey JG, Diaper J, Ellenberger C. Aerosolized salbutamol accelerates the resolution of pulmonary edema after lung resection. Chest 2008;133:845-852.
35. Henry PJ, Rigby PJ, Mackenzie JS, Goldie RG. Effect of respiratory tract viral infection on murine airway β-adrenoceptor function, distribution and density. Br J Pharmacol 1991;104:914-921.
36. Spicuzza L, Di MG, Polosa R. Adenosine in the airways: implications and applications. Eur J Pharmacol 2006;533:77-88.
37. Matthay MA, Folkesson HG, Clerici C. Lung epithelial fluid transport and the resolution of pulmonary edema. Physiol Rev 2002;82:569-600.
38. Ware LB, Matthay MA. Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 2001;163:1376-1383.
39. Tarran R, Button B, Picher M, Paradiso AM, Ribeiro CM, Lazarowski ER, Zhang L, Collins PL, Pickles RJ, Fredberg JJ, et al. Normal and cystic fibrosis airway surface liquid homeostasis: the effects of phasic shear stress and viral infections. J Biol Chem 2005;280:35751-35759.
40. Factor P, Mutlu GM, Chen L, Mohameed J, Akhmedov AT, Meng FJ, Jilling T, Lewis ER, Johnson MD, Xu A, et al. Adenosine regulation of alveolar fluid clearance. Proc Natl Acad Sci USA 2007;104:4083-4088.
41. Neely CF, Jin J, Keith IM. A1-adenosine receptor antagonists block endotoxin-induced lung injury. Am J Physiol 1997;272:L353-L361.
42. Neely CF, Keith IM. A1 adenosine receptor antagonists block ischemia-reperfusion injury of the lung. Am J Physiol 1995;268:L1036-L1046.
43. Sun CX, Young HW, Molina JG, Volmer JB, Schnermann J, Blackburn MR. A protective role for the A1 adenosine receptor in adenosine-dependent pulmonary injury. J Clin Invest 2005;115:35-43.
44. Blackburn MR, Lee CG, Young HW, Zhu Z, Chunn JL, Kang MJ, Banerjee SK, Elias JA. Adenosine mediates IL-13-induced inflammation and remodeling in the lung and interacts in an IL-13-adenosine amplification pathway. J Clin Invest 2003;112:332-344.
45. Ibricevic A, Pekosz A, Walter MJ, Newby C, Battaile JT, Brown EG, Holtzman MJ, Brody SL. Influenza virus receptor specificity and cell tropism in mouse and human airway epithelial cells. J Virol 2006;80:7469-7480.
46. van Riel D, Munster VJ, de Wit E, Rimmelzwaan GF, Fouchier RAM, Osterhaus ADME, Kuiken T. Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am J Pathol 2007;171:1215-1223.
47. Davis IC, Lazarowski ER, Chen FP, Hickman-Davis JM, Sullender WM, Matalon S. Post-infection A77-1726 blocks pathophysiologic sequelae of respiratory syncytial virus infection. Am J Respir Cell Mol Biol 2007;37:379-386.
48. Peebles RS Jr, Moore ML. A mechanistic advance in understanding RSV pathogenesis, but still a long way from therapy. Am J Respir Cell Mol Biol 2007;37:375-377.